2-(4-(4-(5-Benzhydryl-1H-tetrazol-1-yl)butyl)piperazin-1-yl)pyrimidine

ID: ALA4554733

PubChem CID: 155556044

Max Phase: Preclinical

Molecular Formula: C26H30N8

Molecular Weight: 454.58

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccc(C(c2ccccc2)c2nnnn2CCCCN2CCN(c3ncccn3)CC2)cc1

Standard InChI:  InChI=1S/C26H30N8/c1-3-10-22(11-4-1)24(23-12-5-2-6-13-23)25-29-30-31-34(25)17-8-7-16-32-18-20-33(21-19-32)26-27-14-9-15-28-26/h1-6,9-15,24H,7-8,16-21H2

Standard InChI Key:  UZMFETDRCQYXIG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   35.8195   -9.0383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4763   -8.5521    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2187   -7.7765    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3990   -7.7834    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1563   -8.5628    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2554   -8.7986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8585   -8.2472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8256   -9.8554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1210  -10.2694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5364  -10.2587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5395  -11.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2494  -11.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9550  -11.0624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9462  -10.2410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2357   -9.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4130   -9.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7089  -10.2758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7146  -11.0938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4304  -11.4969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1316  -11.0813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6376   -8.4937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2407   -7.9423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0198   -8.1888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.1945   -8.9925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9696   -9.2398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5758   -8.6912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.4015   -7.8919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6210   -7.6411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3508   -8.9380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5228   -9.7381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.3001   -9.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.9062   -9.4382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7297   -8.6360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9526   -8.3901    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  2  0
  2  6  1  0
  6  7  1  0
  1  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  9 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  9  1  0
  7 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4554733

    ---

Associated Targets(Human)

SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.58Molecular Weight (Monoisotopic): 454.2593AlogP: 3.25#Rotatable Bonds: 9
Polar Surface Area: 75.86Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.66CX LogP: 4.08CX LogD: 3.63
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -1.74

References

1. Paudel S, Acharya S, Yoon G, Kim KM, Cheon SH..  (2016)  Exploration of substituted arylpiperazine-tetrazoles as promising dual norepinephrine and dopamine reuptake inhibitors.,  24  (21): [PMID:27647372] [10.1016/j.bmc.2016.09.005]

Source